At the crossroads of targeted treatment and resistance in melanoma

Shigeo Masuda^*, Juan Carlos Izpisua Belmonte

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

ASJC Scopus subject areas

@article{8e21fc355951471abb2eaaa7b86abf21,

title = "At the crossroads of targeted treatment and resistance in melanoma",

author = "Shigeo Masuda and Belmonte, {Juan Carlos Izpisua}",

year = "2013",

month = apr,

doi = "10.1016/S1470-2045(13)70108-6",

language = "English (US)",

volume = "14",

pages = "e136--e137",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "4",

}

TY - JOUR

T1 - At the crossroads of targeted treatment and resistance in melanoma

AU - Masuda, Shigeo

AU - Belmonte, Juan Carlos Izpisua

PY - 2013/4

Y1 - 2013/4

UR - http://www.scopus.com/inward/record.url?scp=84875801840&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(13)70108-6

DO - 10.1016/S1470-2045(13)70108-6

M3 - Letter

C2 - 23561743

AN - SCOPUS:84875801840

SN - 1470-2045

VL - 14

SP - e136-e137

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 4

ER -